M'sia to explore ‘other means’ to get Remdesivir if no access to generic version

Annabelle Lee

Modified 21 May 2020, 1:52 pm

Malaysia may have to resort to “other means” to purchase Remdesivir should the experimental antiviral drug prove effective against Covid-19.

The country does not qualify for subsidised versions of the drug, which is produced and patented by American pharmaceutical company Gilead Sciences Inc...

All Access Plan


per month
Unlimited access to our articles
Comment on all our stories
Gift articles to your friends
Subscribe Now
You can cancel anytime.
Secure and Encrypted
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In